10.1002/art.39618 42 GaneshD.KumarathasanP.ThomsonE
Clinical trials show Tirzepatide reduces HbA1c by up to 2.4 percentage points and achieves body weight loss of up to 20% in patients with type 2 diabetes and obesity
Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health
In a retrospective series of over 2,000 compounded lipotropic injections, the incidence of systemic hypersensitivity was below 0.1 percent, yet clinicians should maintain readiness to administer intramuscular epinephrine and transfer patients to higher-level care when indicated
The formation of ROS is also a consequence of defective mitochondria that, additionally, leads to the activation of the inflammasome and of the pro-inflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B)
An egg intervention improves dietary intakes but does not fill intake gaps for multiple micronutrients among infants in rural Bangladesh